In summary, vGlut2-cre animals consistently showed higher indices of anxiety, with increased freezing time and more time spent in the safety of the dark area when administered CNO, suggesting that vlPAG glutamatergic neuron activation mediated the anxiogenic effect. This evidence concerns the gene SLC17A6 and Anxiety.